Graft Polymer (UK) PLC (LSE:GPL), the polymer modification specialist, has made significant progress on equipment purchases that are tailored to the company's requirements.
The company, which listed on London’s main market in January, has provided advance payments to its relevant suppliers and noted it paid a lower-than-expected price for the equipment; the equipment will double Graft Polymer's compounding capacities.
The ordered equipment includes:
- A twin-screw specially designed and tailored to the company's current reactive extrusion line with sophisticated dosation and underwater pelletising systems;
- Graft thermo-sensitive polymers and porous carriers-based masterbatches within two multifunctional vacuum reactors/dryers;
- Vacuum infra-red dryer tunnel for porous granules;
- Modify complex ozone/plasma, and graft fluoropolymer powders and alloys; and
- Speciality nano-emulsion complex for Pharma and Nutrition bio-supplements via a complex nano emulsification technique.
The company said these items will enable the company to double its compounding capacity. Intensive work has now begun in the company's premises to prepare them for new equipment deployment in the next three-month period. Operations remain unaffected by the transition to better quality equipment.
"The market demand for Graft Polymer is rising and is intensifying. As a result, we have matched this demand with better quality equipment to double the compounding capacities of the company,” said Victor Bolduev, the chief executive officer of Graft Polymer.
"Graft Polymer's ambitious plans for our research and development facility in Slovenia require capacity expansion in order to strengthen our resource to support activity in the most lucrative sectors. Graft Polymer is well-equipped to react to market demand and we look forward to implementing our strategy for 2022-2023 with our new state-of-the-art equipment," he added.